Risk control
Common fraud patterns in peptide supply
The most damaging schemes often begin with credible samples, professional documents or successful small orders.
Non-delivery and impersonation
Some sellers accept payment and never dispatch. Others impersonate a legitimate company, employee or payment account. Legal-name checks, verified contact routes and payment-detail change controls matter before funds are sent.
Substitution and sample-to-bulk switching
A supplier may send a genuine sample or complete small orders correctly, then substitute lower-quality goods when the order becomes large. This is sometimes described as sending A goods first and B goods later. The defence is batch-specific evidence and staged volume, not trust based only on the first success.
Borrowed or altered reports
A real laboratory report can still be unrelated to the goods being sold. Report authenticity and sample-to-batch linkage are separate questions. Public copies should be versioned, and full records should be verified through a controlled route.
Scope note: This article explains BatchVerity’s operating approach. It is not medical, legal or regulatory advice, and it does not establish product availability for a destination.